Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2025-12-24 @ 2:11 PM
NCT ID:
NCT07159295
Eligibility Criteria:
Inclusion Criteria:
* Adults patients with severe asthma treated with benralizumab, who had their first benralizumab dose between July 2019 and October 2020
* Patients who have at least 1 benralizumab injection and with at least 3 months follow-up data from the first injection.
* Give voluntary signed informed consent
Exclusion Criteria:
* Currently receiving benralizumab or any other biologic drug for the treatment of asthma in a clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07159295
Study Brief:
Protocol Section:
NCT07159295